NurExone Biologic Inc (NRX)

Currency in CAD
0.88
-0.04(-4.35%)
Closed·
NRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.850.96
52 wk Range
0.531.14
Key Statistics
Bid/Ask
0.84 / 0.95
Prev. Close
0.88
Open
0.96
Day's Range
0.85-0.96
52 wk Range
0.53-1.14
Volume
79.04K
Average Volume (3m)
66.58K
1-Year Change
57.14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
NRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

NurExone Biologic Inc Company Profile

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other neurological conditions. Its technology includes ExoPTEN for the treatment of acute spinal cord injury and glaucoma; and Exosomes as a drug delivery system for regeneration and healing of specific tissues. The company was founded in 2020 and is based in Toronto, Canada.

Compare NRX to Peers and Sector

Metrics to compare
NRX
Peers
Sector
Relationship
P/E Ratio
−8.2x−2.0x−0.7x
PEG Ratio
0.610.000.00
Price/Book
33.7x−0.2x2.6x
Price / LTM Sales
-7.5x3.4x
Upside (Analyst Target)
192.6%416.3%37.6%
Fair Value Upside
Unlock6.7%5.3%Unlock

Earnings

Latest Release
Aug 27, 2025
EPS / Forecast
-0.02 / -0.03
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NRX Income Statement

People Also Watch

170.78
CIEN
+1.23%
393.49
CLS
+3.65%
36.16
VSAT
-0.90%
54.54
OTEX
-0.82%
277.99
WSP
-2.02%

FAQ

What Stock Exchange Does NurExone Biologic Trade On?

NurExone Biologic is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for NurExone Biologic?

The stock symbol for NurExone Biologic is "NRX."

What Is the NurExone Biologic Market Cap?

As of today, NurExone Biologic market cap is 72.56M.

What Is NurExone Biologic's Earnings Per Share (TTM)?

The NurExone Biologic EPS (TTM) is -0.09.

From a Technical Analysis Perspective, Is NRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has NurExone Biologic Stock Split?

NurExone Biologic has split 0 times.

How Many Employees Does NurExone Biologic Have?

NurExone Biologic has 0 employees.

What is the current trading status of NurExone Biologic (NRX)?

As of 17 Oct 2025, NurExone Biologic (NRX) is trading at a price of 0.88, with a previous close of 0.88. The stock has fluctuated within a day range of 0.85 to 0.96, while its 52-week range spans from 0.53 to 1.14.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.